FDA Reviews Cancer Cases After Zolgensma Gene Therapy in Children
The FDA is reviewing cancer cases reported after children received Zolgensma gene therapy. DNA from the therapy’s viral vectors was found in some tumors.
The FDA is reviewing cancer cases reported after children received Zolgensma gene therapy. DNA from the therapy’s viral vectors was found in some tumors.
